Foghorn Therapeutics (FHTX) Earnings Date & Reports
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FHTX is expected to report earnings to rise 30.61% to -36 cents per share on November 11
Q3'25
Est.
$-0.37
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.11
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.12
The last earnings report on August 05 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 17.46K shares outstanding, the current market capitalization sits at 290.85M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FHTX showed earnings on August 05, 2025. You can read more about the earnings report here.